Amgen Oncology is committed to investigating innovative approaches to fighting cancer, across both hematological malignancies and solid tumors.
Dr. Peter Kufer, Vice President & Innovator of BITE Technology, Amgen Sponsored by Amgen Oncology
Advertisement
Articles by Dr. Peter Kufer, Vice President & Innovator of BITE Technology, Amgen Sponsored by Amgen Oncology
Advertisement
Latest Updated Articles
BiTE Platform and the Evolution Toward Off-The-Shelf Immuno-Oncology ApproachesPublished: June 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
4
SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma
5